BAILEY BUCKNER: Open Payments
NPI 1962276030 · CLARKSVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,728 in 83 payments from 15 companies in 2025. Trend: 2023 $96 · 2024 $1,027 · 2025 $1,728
Food & beverage: $1,716Education: $13
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $250 |
| Axsome Therapeutics, Inc. | 8 | $186 |
| Lundbeck LLC | 6 | $168 |
| Alkermes, Inc. | 10 | $167 |
| Neurocrine BioSciences, Inc. | 5 | $157 |
| Corium, LLC | 7 | $151 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $148 |
| Supernus Pharmaceuticals, Inc. | 7 | $119 |
| Vanda Pharmaceuticals Inc. | 4 | $103 |
| Biogen, Inc. | 3 | $75 |
Products named: CAPLYTA, REXULTI, Auvelity, ARISTADA, INGREZZA, Azstarys, TRINTELLIX, Qelbree.
Industry payments across TN — which companies pay providers there.
